Joshua Meeks
@JoshMeeks
Urologic Oncologist and Scientist at Northwestern University
K-index:3.7
ID:55318121
https://meekslab.org 09-07-2009 18:30:26
2,1K Tweets
3,5K Followers
3,7K Following
#AUA24 Amer. Urol. Assn. annual meeting-plenary👉Joshua Meeks ‘s excellent talk on challenges of neobladder👉Who should get a neobladder after radical surgery for #bladdercancer ?👇quote by W Buffett: the secret to happiness in life is low expectations OncoAlert SWOG Cancer Research Network Seth lerner
Great work by Niklas Klümper et al. finding that 24% of mUC have Nectin4 ampl, which predicts ⬆️ORR (96% vs 32%) & ⬆️OS with the ADC #EV . Excited to see EV data for MBC presented at ASCO by Antonio Giordano, MD PhD & to study this biomarker in breast cancer. Congrats! ascopubs.org/doi/full/10.12…
⚡️ NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
#BladderCancer #Immunology Markus Eckstein
Journal of Clinical Oncology
ascopubs.org/doi/10.1200/JC…
Very happy to share our study published Journal of Clinical Oncology ! ascopubs.org/doi/full/10.12…
➡️Patients with mUC with NECTIN4 amplifications (occurring in app. 25%) show remarkable responses to single-agent EV, with a 96% objective response rate compared to 32% in non-amplified cases. NECTIN4…
We are happy to share our new study published today Journal of Clinical Oncology (👉 ascopubs.org/doi/10.1200/JC…) on the role of NECTIN4 amplifications to predict responses to Enfortumab Vedotin treatment in metastatic urothelial cancer.
With a huge contribution of our multinational team we uncovered…
New #JITC short report: Spatial comparison of molecular features associated with resistance to pembrolizumab in BCG unresponsive bladder cancer bit.ly/3UkUNVL Noah Frydenlund Bonnie Choy, MD Joshua Meeks
Looking forward to Joshua Meeks joining us for UF Health Cancer Center grand rounds this week cancercenter-a2.sites.medinfo.ufl.edu/wordpress/file…
Excited to co-host w/𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 an amazing all-star ⭐️faculty for Precision Onc summit in #Cleveland on April 13 Jonathan Rosenberg MD Manmeet Ahluwalia, MD, MBA, FASCO JAGarciaMD Dr Amit Mahipal Maryam Lustberg MD MPH Narjust Florez, MD, FASCO Jessica Geiger Yousef Zakharia Paolo Tarantino Pedro C Barata, MD MSc FACP Leonard Appleman
👇👇
Great overview about the question: How can novel spatial transcriptomics/ proteomics methodology improve (translational) cancer research ?European Association of Urology (EAU) #EAU24 Markus Eckstein
Christoph Kuppe Joshua Meeks Petros Grivas UroToday.com Viktor Grünwald Uromigos European Association of Urology (EAU) Axel S. Merseburger
Congrats to brilliant Dr. Bishoy M. Faltas well deserved CRO position! Your vision, persistence & hard work will make a difference! OncoAlert Olivier Elemento WCM Englander Institute for Precision Medicine Scott Tagawa Cora Sternberg Hsieh Lab Gavin Ha Omar Mian Kent Mouw Joshua Meeks Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Shilpa Gupta
This one doesn’t disappoint. Crushed a bit by Matt Galsky biomarker comment “if you know the future predicting the future isn’t helpful” Tom Powles Brian Rini, MD podcasts.apple.com/us/podcast/the…
The results of the EV-302 trial, which reported improved OS & DFS for patients with mUC treated with 1L EV+P over chemo, could be 'the moon landing' for anyone who cares for patients with UC. Joshua Meeks explains for #ASCODailyNews : brnw.ch/21wIk4x #gucsm
An uplifting Easter episode of GU Cast full of good news for metastatic bladder cancer patients! With two of the cheeriest medical oncologists you could ever meet Enrique Grande DrAndrewWeickhardt youtu.be/_YdtO9QwWiY?si…
Amazing trip to visit Hsieh Lab Petros Grivas Fred Hutchinson Cancer Center UW Urology Gavin Ha Bruce Montgomery. VA Puget Sound Really impressive bladder/GU team!
This week on The Podcast: Dr. James Eastham from UrologyMSK discusses how to manage biochemical recurrence after prostatectomy. #UroSoMe YUO DrBagrodia Bernie Bochner, MD Joshua Meeks Dr. Darren Feldman Rich Matulewicz Behfar Ehdaie 𝙳𝚊𝚟𝚒𝚍 𝙲𝚊𝚗𝚎𝚜 Society of Urologic Oncology open.spotify.com/episode/1DuLI9…
Submit an abstract by February 27 for the AACR Special Conference on Bladder Cancer (May 17-20, Charlotte, NC), chaired by Lars Dyrskjøt, Donna Hansel MD, PhD, Dan Theodorescu, and Tahlita C. M. Zuiverloon. Learn more:
bit.ly/3wmjOqh
#AACRbladder24 Lars Dyrskjøt Tahlita Zuiverloon MD PhD
SWOG Cancer Research Network S1937 ph3 trial in advanced urothelial cancer testing eribulin/gemcitabine vs SOC has now reopened to accrual, accommodating new changes in the standard of care through a leaner study design. No limit to number of prior lines of therapy!
swog.org/clinical-trial…
Happy to report that S1806 has completed accrual. This is the largest TMT study evaluating CRT+atezo vs CRT alone in muscle invasive bladder cancer. Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO Petros Grivas Shilpa Gupta Guru P. Sonpavde, MD splernerMD Tom Powles Thomas Flaig
